NYSCF scientists one step closer to cell therapy for multiple sclerosis patients

New study shows efficiency at making living human cells from MS patients’ skin samples

NEW YORK, NY (July 24, 2014) – Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient’s own cells.

For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they developed an accelerated protocol to induce these stem cells into becoming oligodendrocytes, the myelin-forming cells of the central nervous system implicated in multiple sclerosis and many other diseases.

Continue reading this Stem Cell News article by clicking here

~~~~~~~~~~~~~~~~~~~~

Keep CURRENT and up to date, with MS News and Information

Sign-up for emails

WATCH OUR MS EDUCATIONAL VIDEOS by Topic,

found here: www.youtube.com/msviewsandnews

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews